title: Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C.
authors.affiliation: Dermatology department, Hospital General Universitario de Alicante, Alicante, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Leiva-Salinas
authors.forename: L
authors.initials: L
authors.lastname: Francés
authors.forename: I
authors.initials: I
authors.lastname: Marin-Cabanas
authors.forename: M P
authors.initials: MP
authors.lastname: Arribas Granados
authors.forename: J F
authors.initials: JF
authors.lastname: Silvestre
mesh_terms: D018926:Anti-Allergic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications*; D039563:Histamine H1 Antagonists, Non-Sedating / Q000627:therapeutic use; D006801:Humans; D017336:Loratadine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D000069444:Omalizumab / Q000009:adverse effects / Q000627:therapeutic use*; D014581:Urticaria / Q000150:complications / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D039563:Histamine H1 Antagonists, Non-Sedating; D000069444:Omalizumab; D017336:Loratadine; C121345:desloratadine